梅州妇科宫颈炎怎样治梅州意外怀孕的解决,梅州处女膜手术费是多少,梅州做处女膜修补要多少钱,梅州现在做人流多少钱呀,梅州有炎症能做流产吗,梅州普通打胎价格,梅州怎么治疗轻度附件炎好

Call it futuristic, but in reality, it's science redirected to make people feel better.Eric Rice, founder and CEO of Quanta, gave a virtual tour of his Los Angeles-based lab which produces the muscle Rub.“We have the brain and the body,” Rice said. “The brain does all the calculation. Its where we input information and then the body itself is a gigantic freezer with chambers.”As Rice showed the machines that produce Quanta, and how they work, he said, “Here’s our batches of muscle rub. You can see everything being made. Everything’s organic, natural, grown from the earth. We don’t use any synthetic materials for any of our products.”Running Quanta, he's leading the charge in new technology geared toward pain management."Pain right now affects 22% of the world’s population, or 1.7 billion people daily,” Rice said. “Chronic pain, pain that lasts 3 weeks or longer, that’s considered chronic.”Rice is a former baseball player, so pain is something that Rice knows all too well.“I’m a former athlete and I have horrible knees, shoulders and back,” Rice said. “We started out with a simple muscle rub with a few ingredients and CBD was a great place for us to start. It’s been around, patented, but used for one pharmaceutical solution.”He took the concept of CBD or cannabidiol and applied his knowledge of quantum physics and biochemistry to change molecules, which then makes ingredients more effective.“Imagine my finger point being a nucleus. When you’re alive, electrons rotate like this, really far really fast from the center,” Rice said. “As you die and age, they slow down and get closer to the nucleus. What we do is use our technology to speed it back up and stabilize the cell so we’re creating excited state molecules that don’t ionize and oxidize.”It's a unique business concept, and it's one that even he admits sounds out of this world.“We use really contemporary if not futuristic science to increase the amount of energy to molecules so that we use an ingredient for your skin or your health it performs 3-500 % better than anything else you’ll find in the market,” Rice said.The market he's referring to is topical CBD, which is seemingly everywhere these days.Dr. Richard Sorgnard specializes in electrical cell signaling technology, which is a medical device that treats severe pain.“These are placed on the body in a specific array depending on the diagnosis and then when the machine is turned on it will deliver 12 types of electrical stimulation,” Sorgnard said.He recommends Quanta to his patients, before, during and after the treatment. The machine, he says, treats all kinds of pain and feels like a massage. With Quanta, he says, patients are resolving their problems and not masking them.“We noticed it made a great afterglow for the treatment- when we use them together the patients get a better response for the initial sensation,” Sorgnard said.Rice says Quanta is expanding beyond topical pain relief and into vitamins, supplements and skin care.“I can absolutely see us heavily involved in agriculture, food, beverage anything having to do with energy and natural ingredients is really kind of our focus. Pharmaceutical as well as helping people grow plant matter on different planets,” Rice said.He says Quanta has delayed his own surgeries for years and believes polarizing ingredients is the world's next step into the future and beyond.Rice’s website does note that Quanta’s effectiveness has not been evaluated by the FDA. The FDA adds that while there might be some to CBD products, there are potential side effects that should weighed. More info can be seen here. 3622

CHICAGO -- Right now, nine COVID-19 vaccines are in or near a large-scale human trial phase. But enrollment of minorities in the trials remains a challenge. This is despite a disproportionate number of African-Americans impacted by the coronavirus.Earlier this month, ads from the National Institutes of Health began airing asking Black people and Latinos to volunteer for the coronavirus vaccine trials.“Operation Warp Speed” may be moving quickly, but pharmaceutical companies are having a difficult time getting Black and brown participants.“What we really bring to the table is moral persuasion and encouraging our population to participate in safe and ethical clinical trials,” said Reverend Anthony Evans, the president of the National Black Church Initiative. Over the past 15 years, they’ve worked with the pharmaceutical industry to boost Black representation in more than a dozen previous clinical trials.“I think that we can be a major help to both the government and the pharmaceutical industry if they use us,” said Evans.The Black community has been hesitant to take part in medical research and clinical trials because of a history of past abuse.Most infamously, the 40-year Tuskegee Syphilis Experiment that used Black men to study what happened when the disease went untreated.“They were just basically experimented on without their knowing about it or their understanding what was happening. And a lot of people had very bad outcomes because of this,” said Dr. Emily Landon, an infectious disease specialist at University of Chicago Medicine.A recent Pew study found that Black Americans are still more skeptical of experimental treatments and a potential COVID-19 vaccine than Hispanic and white adults.Add to that, most of the current trials are recruiting mainly online, something experts say often results in mostly white people enrolling.“We will know more and be able to do a better job in caring for our friends and patients of color if we have more participation in these trials,” said Landon.Moderna had to delay trials because of a lack of diversity. As of earlier this week, 13% of Moderna’s enrollment volunteers were Black and 51% white. At the same time, only 8% of Pfizers volunteers are Black and 75% white.“They are going to have a significant shortfall of data when it comes down to African Americans and other groups, especially Latinos, and simply because they have not made the efforts,” said Evans.In the end, the vaccine must be at least 50% effective to receive FDA approval. Without a diverse group of volunteers, experts say it could be difficult to know just how safe and effective the vaccine actually is across races. 2672

CARDIFF, Calif. (KGTV) - Three boys are recovering from an angry wasp attack at a park in Cardiff.Along Windsor Road, feet from an elementary school, five boys between 7 and 14 years old were inside a private park in the Park Place community two Sundays ago. They were about a 100 feet from the fenceline along Windsor Road. Frank Bocchini's son was the oldest boy in the group."Doing what young boys do, exploring and having fun in nature," said Bocchini.The fun quickly turned into a nightmare."He saw the wasps and told the young boys to stay away from there," said Bocchini.Bocchini's son was the first to see the insects near a tunnel structure. "The wasps reacted quickly after he said that. It was a nest that quickly turned into a swarm...screaming and crying, because they were getting hit," said Bocchini.Three of the five kids were stung, including two 7-year-old boys who were stung dozens of times."The older boys were trying to get the wasps tangled in the young boys' hair," said Bocchini.Bocchini's son and another boy frantically tried to help the other children. "At one point, the whole jacket was covered in wasps on this young boy. He told the boy to take the jacket off and run," said Bocchini.That boy did, and eventually ran out of harm's way."He was upset and scared," said Bocchini. The 7-year-old boy ended up in the emergency room with 24 stings and hives on his body. The incident unfolded as wasp season should be wrapping up. Experts tell us the hot weather has extended the season along with the dangers.The property management company for Park Place confirmed a pest service relocated the yellow jackets. Experts say you should run from wasps, and running through trees and bushes may help slow them down. If you're stung, don't take the stinger out with tweezers. Instead, scrape it out with a credit card so you don't push more of the venom into your body. 1899

CHAPEL HILL, N.C. – The pandemic ignited a global fight against a fast-moving and deadly virus. “In the beginning, a lot of manufacturers shifted gears and started doing more COVID manufacturing," said Dr. Melissa Miller, a clinical lab director.Manufacturers began ramping up testing production and diverting supplies to combat the virus. But in the months ahead, laboratories started facing another threat due to a strained supply chain. Not only were labs facing shortages of supplies needed for COVID-19, but several other common illnesses. “Probably the biggest one was for sexually transmitted diseases, chlamydia, gonorrhea being the most common ones we diagnose in the labs," said Dr. Miller. The American Society for Microbiology (ASM) partnered with the Association of Supply Chain Management to track shortages across the country. ASM leaders say the data collection tool provides a near real-time visualization into the capacity, utilization, and resources necessary to meet consumer and patient demand for testing.“It was a bit of a surprise of how overwhelming it was throughout the country and that there weren’t just hot spots; it really indicated that this was a major national issue," said Dr. Miller. “The first week of the survey, almost 90% of the laboratories that responded reported a shortage of tests for STI’s.”Dr. Miller has a leadership role within ASM and has also been experiencing shortages in the lab firsthand."It’s a guessing game. Many times we don’t know when the next shipment is coming for some of the items we’re short on," said Dr. Miller. Since September, 134 CLIA-certified labs have responded to the survey, which is updated every week. Dr. Miller says the figure for STI testing supplies has improved but is still too high around 50%. And she says 47% of labs have a shortage of non-COVID-19 testing supplies to detect routine bacteria, including the bacteria that cause strep throat, pneumonia, bronchitis, and urinary tract infections."Since June, I have been worried about this exact moment," said Dr. Miller. “You have the COVID surge, the upcoming holidays, and the winter season, and you have respiratory season."The survey also showed 74% of labs have a shortage of commercial testing kits for COVID-19.She says the hope is to include more labs in the weekly survey to get a clearer picture of the supply chain issues.“Data is power; we need the data that this is a problem. And getting some federal action on this, I think, is critical," said Dr. Miller. And she says the longer labs wait for critical supplies, the more Americans in need of critical testing could be turned away. 2641

CARLSBAD, Calif. (KGTV) -- If you haven’t yet seen the spectacularly colorful Carlsbad Flower Fields in person, this weekend is your last chance for the season. The Flower Fields at Carlsbad Ranch are set to close for the season on May 13. The nearly 50 acres of Tecolote Ranunculus flowers have been in bloom since March.According to the ranch’s website, the best time to behold the beauty is from mid-March through mid-April.The fields are a result of more than 85 years of cultivation that began when an early settler, Luther Gage, settled in the area in the 1920s.Adult tickets are and tickets for children three through 10 cost . Click here for more information. 686